ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

March Dedicated To Colorectal Cancer Awareness; New Advocacy Group.

March 10, 2000

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Young Investigator Grants Available

July 8, 1977